{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:32:51Z","timestamp":1790649171944,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.cca.2015.02.039","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T02:17:01Z","timestamp":1425435421000},"page":"37-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Autoimmune peripheral neuropathies"],"prefix":"10.1016","volume":"449","author":[{"given":"Pierre R.","family":"Bourque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi Warman","family":"Chardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Massie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2015.02.039_bb0005","series-title":"Peripheral neuropathy","first-page":"9","article-title":"Gross anatomy of the peripheral nervous system","author":"Gardner","year":"2005"},{"key":"10.1016\/j.cca.2015.02.039_bb0010","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/mus.20762","article-title":"Ganglioside mimicry and peripheral nerve disease","volume":"35","author":"Yuki","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cca.2015.02.039_bb0015","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMra041347","article-title":"Chronic inflammatory demyelinating polyneuropathy","volume":"352","author":"Koller","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2015.02.039_bb0020","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.clinph.2013.03.025","article-title":"Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies","volume":"124","author":"Uncini","year":"2013","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.cca.2015.02.039_bb0025","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2015.02.039_bb0030","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.410410304","article-title":"Appropriate number of plasma exchanges in Guillain-Barr\u00e9 syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 Syndrome","volume":"41","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cca.2015.02.039_bb0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2015.02.039_bb0040","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.35.8.1096","article-title":"Plasmapheresis and acute Guillain-Barr\u00e9 syndrome. The Guillain-Barr\u00e9 Syndrome Study Group","volume":"35","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2015.02.039_bb0045","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 Study Group","volume":"326","author":"van der Meche","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2015.02.039_bb0050","first-page":"586","article-title":"Double-blind trial of intravenous methylprednisolone in Guillain-Barr\u00e9 syndrome. Guillain-Barr\u00e9 Syndrome Steroid Trial Group","volume":"341","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2015.02.039_bb0055","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain-Barr\u00e9 syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.cca.2015.02.039_bb0060","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9","article-title":"Inflammatory infiltrates in sural nerve biopsies in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating neuropathy","volume":"19","author":"Schmidt","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cca.2015.02.039_bb0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-196905000-00001","article-title":"The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis","volume":"48","author":"Asbury","year":"1969","journal-title":"Medicine"},{"key":"10.1016\/j.cca.2015.02.039_bb0070","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","article-title":"Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy","volume":"39","author":"Hafer-Macko","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cca.2015.02.039_bb0075","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0022-510X(99)00173-2","article-title":"Clinical presentation and outcome of Guillain-Barr\u00e9 and related syndromes in relation to anti-ganglioside antibodies","volume":"168","author":"Carpo","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.cca.2015.02.039_bb0080","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-1-4419-7877-6_17","article-title":"Pathological roles of ganglioside mimicry in Guillain-Barr\u00e9 syndrome and related neuropathies","volume":"705","author":"Yu","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.cca.2015.02.039_bb0085","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/mus.20520","article-title":"Electrophysiological subtypes and prognosis of childhood Guillain-Barr\u00e9 syndrome in Japan","volume":"33","author":"Nagasawa","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cca.2015.02.039_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02284784","article-title":"Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barr\u00e9 syndrome","volume":"25","author":"Griffin","year":"1996","journal-title":"J Neurocytol"},{"key":"10.1016\/j.cca.2015.02.039_bb0095","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-510X(99)00056-8","article-title":"Autoantibodies to GM1b and GalNAc-GD1a: relationship to Campylobacter jejuni infection and acute motor axonal neuropathy in China","volume":"164","author":"Yuki","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.cca.2015.02.039_bb0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2003.12.004","article-title":"The Guillain-Barr\u00e9 syndrome: a true case of molecular mimicry","volume":"25","author":"Ang","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.cca.2015.02.039_bb0105","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ana.1012","article-title":"Animal model of axonal Guillain-Barr\u00e9 syndrome induced by sensitization with GM1 ganglioside","volume":"49","author":"Yuki","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cca.2015.02.039_bb0110","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ana.410380516","article-title":"Anti-ganglioside GM1 antibodies in Guillain-Barr\u00e9 syndrome and their relationship to Campylobacter jejuni infection","volume":"38","author":"Rees","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cca.2015.02.039_bb0115","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.56.8.1104","article-title":"Clinical features and prognosis of Miller Fisher syndrome","volume":"56","author":"Mori","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2015.02.039_bb0120","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1212\/WNL.43.10.1911","article-title":"Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barr\u00e9 syndrome: clinical and immunohistochemical studies","volume":"43","author":"Chiba","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2015.02.039_bb0125","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410310619","article-title":"Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome","volume":"31","author":"Chiba","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cca.2015.02.039_bb0130","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp.56.2.204","article-title":"Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside","volume":"56","author":"Willison","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cca.2015.02.039_bb0135","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/jnnp.2006.087940","article-title":"Anti-ganglioside complex antibodies in Miller Fisher syndrome","volume":"77","author":"Kaida","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cca.2015.02.039_bb0140","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jns.2004.01.005","article-title":"Clinical correlates of serum anti-GT1a IgG antibodies","volume":"219","author":"Nagashima","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.cca.2015.02.039_bb0145","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jneuroim.2003.11.017","article-title":"Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination","volume":"148","author":"Nishimoto","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cca.2015.02.039_bb0150","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1167\/iovs.08-3333","article-title":"Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles","volume":"50","author":"Liu","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cca.2015.02.039_bb0155","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1212\/01.wnl.0000324266.95814.74","article-title":"Acute ophthalmoplegia (without ataxia) associated with anti-GQ1b antibody","volume":"71","author":"Lee","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2015.02.039_bb0160","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jnnp.2010.222836","article-title":"Ataxic Guillain-Barr\u00e9 syndrome and acute sensory ataxic neuropathy form a continuous spectrum","volume":"82","author":"Ito","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cca.2015.02.039_bb0165","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00415-008-0775-0","article-title":"Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases","volume":"255","author":"Ito","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.cca.2015.02.039_bb0170","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jnnp-2012-302833","article-title":"The spectrum of immune-mediated autonomic neuropathies: insights from the clinicopathological features","volume":"84","author":"Koike","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cca.2015.02.039_bb0175","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jneuroim.2007.11.017","article-title":"Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barr\u00e9 syndrome","volume":"194","author":"Jacobs","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cca.2015.02.039_bb0180","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/1531-8249(199912)46:6<910::AID-ANA14>3.0.CO;2-2","article-title":"Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia","volume":"46","author":"McLeod","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cca.2015.02.039_bb0185","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.52.3.498","article-title":"Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy","volume":"52","author":"Bouchard","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2015.02.039_bb0190","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1468-1331.2006.01278.x","volume":"13","author":"Hughes","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cca.2015.02.039_bb0195","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force","volume":"41","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2015.02.039_bb0200","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1212\/WNL.54.3.615","article-title":"Distal acquired demyelinating symmetric neuropathy","volume":"54","author":"Katz","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2015.02.039_bb0205","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","article-title":"Clinical spectrum of chronic acquired demyelinating polyneuropathies","volume":"24","author":"Saperstein","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cca.2015.02.039_bb0210","first-page":"301","article-title":"Peripheral neuropathy and anti-MAG antibodies","volume":"3","author":"Latov","year":"1988","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.cca.2015.02.039_bb0215","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ana.410360313","article-title":"Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy","volume":"36","author":"Nobile-Orazio","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cca.2015.02.039_bb0220","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/B978-0-444-52902-2.00025-4","article-title":"Neuropathy and monoclonal gammopathy","volume":"115","author":"Nobile-Orazio","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.cca.2015.02.039_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002827.pub3","article-title":"Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies","volume":"5","author":"Lunn","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cca.2015.02.039_bb0230","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1212\/WNL.0b013e318296e92b","article-title":"Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy","volume":"80","author":"Leger","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2015.02.039_bb0235","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1600-0404.1992.tb06033.x","article-title":"Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies","volume":"85","author":"Nobile-Orazio","year":"1992","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.cca.2015.02.039_bb0240","first-page":"1242","article-title":"A review of POEMS syndrome","volume":"27","author":"Dispenzieri","year":"2013","journal-title":"Oncology"},{"key":"10.1016\/j.cca.2015.02.039_bb0245","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1212\/WNL.51.6_Suppl_5.S22","article-title":"Multifocal motor neuropathy: diagnosis and treatment","volume":"51","author":"Pestronk","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2015.02.039_bb0250","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1212\/WNL.0b013e3181ff94c2","article-title":"Multifocal motor neuropathy: association of anti-GM1 IgM antibodies with clinical features","volume":"75","author":"Cats","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2015.02.039_bb0255","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1468-1331.2012.03767.x","article-title":"Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy","volume":"20","author":"Galban-Horcajo","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cca.2015.02.039_bb0260","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/WNL.0b013e3181ff94e6","article-title":"Are anti-ganglioside antibodies of clinical value in multifocal motor neuropathy?","volume":"75","author":"Gooch","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2015.02.039_bb0265","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/brain\/124.10.1968","article-title":"The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies","volume":"124","author":"Willison","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.cca.2015.02.039_bb0270","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/jnnp.2009.185736","article-title":"Chronic ataxic neuropathies associated with anti-GD1b IgM antibodies: response to IVIg therapy","volume":"81","author":"Attarian","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cca.2015.02.039_bb0275","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jocn.2005.09.008","article-title":"Rituximab therapy in chronic inflammatory demyelinating polyradiculoneuropathy with anti-SGPG IgM antibody","volume":"13","author":"Gono","year":"2006","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.cca.2015.02.039_bb0280","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2007.10.025","article-title":"Induction of experimental ataxic sensory neuronopathy in cats by immunization with purified SGPG","volume":"193","author":"Ilyas","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cca.2015.02.039_bb0285","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-510X(00)00342-7","article-title":"Anti-sulfatide IgM antibodies in peripheral neuropathy","volume":"176","author":"Carpo","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.cca.2015.02.039_bb0290","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s004150070090","article-title":"Polyneuropathy attributes: a comparison between patients with anti-MAG and anti-sulfatide antibodies","volume":"247","author":"Erb","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.cca.2015.02.039_bb0295","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/mus.880171108","article-title":"Treatable gait disorder and polyneuropathy associated with high titer serum IgM binding to antigens that copurify with myelin-associated glycoprotein","volume":"17","author":"Pestronk","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cca.2015.02.039_bb0300","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/01.SMJ.0000117799.38569.B8","article-title":"GALOP syndrome: case report with 7-year follow-up","volume":"97","author":"Alpert","year":"2004","journal-title":"South Med J"},{"key":"10.1016\/j.cca.2015.02.039_bb0305","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(99)00250-7","article-title":"Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies","volume":"104","author":"Ritz","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cca.2015.02.039_bb0310","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/WCO.0b013e328357a77f","article-title":"Autoantibodies in immune-mediated neuropathies","volume":"25","author":"Chavada","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.cca.2015.02.039_bb0315","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0165-5728(01)00434-9","article-title":"Anti-GD1a antibodies from an acute motor axonal neuropathy patient selectively bind to motor nerve fiber nodes of Ranvier","volume":"121","author":"De Angelis","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cca.2015.02.039_bb0320","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1196\/annals.1398.031","article-title":"A new line immunoassay for the multiparametric detection of antiganglioside autoantibodies in patients with autoimmune peripheral neuropathies","volume":"1109","author":"Conrad","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2015.02.039_bb0325","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1212\/WNL.56.2.228","article-title":"Neuropathy and IgM M-proteins: prognostic value of antibodies to MAG, SGPG, and sulfatide","volume":"56","author":"Eurelings","year":"2001","journal-title":"Neurology"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898115001230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898115001230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T13:53:07Z","timestamp":1537797187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898115001230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":65,"alternative-id":["S0009898115001230"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2015.02.039","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune peripheral neuropathies","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2015.02.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}